Skip to content
Search

Latest Stories

Community pharmacists asked to help increased uptake of flu jabs amid concerns over low level of population immunity

Amid concerns over the impact that influenza could have this winter because of a lower level of population immunity, the government is setting ambitious targets for the national flu immunisation programme for 2021/2022 which stars this autumn.

In a jointly published letter by the Department of Health and Social Care (DHSC), Public Health England (PHE) and NHSE&I, community pharmacists have been asked to further support increased uptake rates and offer further protection to this vulnerable group of patients.


The regulator's uptake ambition is to achieve a minimum of 85 per cent in those aged 65 years and older; a minimum of 75 per cent uptake across the under 65 years clinical risk group, pregnant women and the aged 50 to 64 years; and at least 70 per cent uptake in children.

Additionally, the aim is to reduce levels of inequality with no group or community having an uptake of more than 5 per cent lower than the national average.

At the end of February 2021, the NHS vaccination services had vaccinated a record 80.9 per cent of those aged 65 years and over in England, exceeding the World Health Organization uptake ambition of 75 per cent. The services also achieved the highest recorded vaccination levels for frontline healthcare workers, 2- and 3-year-olds, and at-risk groups.

The letter also highlights the risk of a lower level of population immunity against influenza because of non-pharmaceutical intervention measures taken to protect the population in response to the Covid-19 pandemic. 

As restrictions lift and the population returns to pre-pandemic norms of social mixing and social contact, the letter draws attention to how this could result in the 2021/2022 winter having co-circulation of seasonal influenza virus (and other respiratory viruses) and Covid-19. 

With modelling suggesting the influenza impact could be up to 50 per cent larger than that typically seen, it reinforces the message that the vaccination programme will be essential to reduce pressure on the health and social care system this winter.

Contractors are advised to read the national flu immunisation programme update letter in full but a summary of the key information for contractors is provided below.

Eligible groups

The expanded influenza vaccination programme introduced in the 2020/21 season continues and the letter confirms that the vaccination of 50 to 64-year-olds will, as part of measures to protect those aged 50 years and older from the risk of hospitalisation, also continue as a temporary measure.

Therefore, those eligible for NHS influenza vaccination in 2021/22 from community pharmacies are:

  • those aged 18 to 49 years in clinical risk groups;
  • pregnant women;
  • those aged 50 years and over;
  • those in long-stay residential care homes;
  • carers;
  • close contacts of immunocompromised individuals; and
  • frontline health and social care staff employed by:
  • a registered residential care or nursing home;
  • registered domiciliary care provider;
  • a voluntary managed hospice provider; and
  • Direct Payment (personal budgets) and/or Personal Health Budgets, such as Personal Assistants.

The letter reinforces the Government’s expectation that all frontline health and social care workers should have an influenza vaccination to protect those they care for.

More For You

AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Numark launches new digital consultation platform to support independent prescribers

Harry McQuillan, Chairman of Numark

Numark launches DigiPharma to empower independent prescribers

Numark has launched a new digital consultation platform, called DigiPharma, designed to support both current and future independent prescribers (IPs) in making full use of their qualifications.

The revolutionary cloud-based prescribing recording platform is now available exclusively to Numark members.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less